Medical treatment of prosthetic vascular graft infections: Review of the literature and proposals of a Working Group.
|
| Abstract |
More than 400000 vascular grafts are inserted annually in the USA. Graft insertion is complicated by infection in 0.5-4% of cases. Vascular graft infections (VGIs) are becoming one of the most frequent prosthesis-related infections and are associated with considerable mortality, ranging from 10 to 25% within 30 days following the diagnosis. Treatment of VGI is based on urgent surgical removal of the infected graft followed by prolonged antibiotherapy. Data regarding the best antibiotherapy to use are lacking since no well designed trial to study antimicrobial treatment of VGI exists. Moreover, since VGIs demonstrate very specific pathophysiology, guidelines on other material-related infections or infective endocarditis treatment cannot be entirely applied to VGI. A French multidisciplinary group gathering infectious diseases specialists, anaesthesiologists, intensivists, microbiologists, radiologists and vascular surgeons was created to review the literature dealing with VGI and to make some proposals regarding empirical and documented antibiotic therapy for these infections. This article reveals these proposals.
|
|---|---|
| Authors | M Revest, F Camou, E Senneville, J Caillon, F Laurent, B Calvet, P Feugier, M Batt, C Chidiac, Groupe de Réflexion sur les Infections de Prothèses vasculaires (GRIP) |
| Journal | International journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 46 Issue 3 Pg. 254-65 (Sep 2015) ISSN: 1872-7913 [Electronic] Netherlands |
| PMID | 26163735 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review) |
| Copyright | Copyright © 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved. |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!